The BioIndustry Association (BIA) is the voice of the innovative life sciences and biotech industry, enabling and connecting the UK ecosystem so that businesses can start, grow and deliver world-changing innovation.

Explore opportunities to influence, connect and save with the BIA.

Influence policymakers

 Influence

policymakers, ensuring your voice is heard on matters that are critical to the success of your organisation

Connect at BIA events

Connect

with the UK ecosystem through industry-leading events, expert committees and overseas missions

Save

Save

money with the BIA Business Solutions purchasing programme, helping your business grow cost-effectively


Biotech and life sciences news and insights

Press Releases

BIA welcomes Chancellor’s life sciences growth package

The UK Government has announced a package of investment and policy initiatives to support the continued growth of the sector following a meeting of the Chancellor, Jeremy Hunt MP, and industry leaders in Downing Street.  

BIA launches #BIGIMPACT campaign to encourage talent with digital skills to start a career in biotech

The BioIndustry Association (BIA) is launching #BIGIMPACT, a new campaign encouraging people with digital and data-driven skills to consider a career in the biotech industry. The campaign shines a spotlight on new career pathways that are possible in biotech, for example, an AI engineer, bioinformatician or data analyst.

Venture deals continue to flow for UK biotech under dark clouds

The first quarter of 2023 has seen deal flow continue for the UK’s innovative life science and biotech companies at all stages of development, new data from the UK BioIndustry Association and Clarivate shows. As global macro-economic headwinds, suppressed public markets and political uncertainty weighed on investor confidence, venture investment remained steady, with private UK biotechs securing £258 million across 20 deals, with an average deal size of £13 million.

BIA calls on NICE to refresh evidence informing how rare disease medicines are evaluated and paid for

The UK BioIndustry Association has today published research suggesting the UK’s medicines evaluation body is basing its methods and processes for evaluating medicines for rare diseases on outdated evidence. Rare insights: examining the social values of treating rare diseases presents the findings of primary research into public opinion on how treatments for rare diseases should be evaluated and funded within the NHS.

 

Member News

Cambridge Wide Open Day to drive inclusive collaboration

o2h group launches the Cambridge Wide Open Day, offering a unique insight into the city best known as the ‘UK Centre of Science & Technology’.

Stablepharma and BB-NCIPD Ltd (Bul Bio) to develop a fridge-free Tetanus mono vaccine.

Stablepharma Ltd. and BB-NCIPD Ltd. (Bul Bio) have signed a second agreement for the exclusive bulk supply and commercialization of the Tetanus vaccine (SPVX06), following a similar arrangement for the Tetanus diphtheria vaccine (SPVX02) last year.

Coulter Partners announces Gerben van 't Klooster as chief development officer at TargED Biopharmaceuticals

Coulter Partners, is pleased to announce the placement of Gerben van 't Klooster as Chief Development Officer (CDO) of TargED Biopharmaceuticals.

Discovery Park and EKC Group join forces to boost STEM careers in Kent

A partnership has been forged between Discovery Park and EKC Group, a further education provider, to inspire more of Kent’s young people to experience a career in science, technology, engineering and maths.

 

BIA blog

Is it time for a new tool box for drug research and development?

In this blog, Professor James Fildes, CEO and Chief Scientist and Amy Stewart, Research Technician at Pebble Biotechnology Laboratories argue that the significant difference in human to mice gene expression in various tissues could explain why many drugs that are successful in rodents fail in humans.

CEO Update - 30 May 2023

Last Thursday was a big day for our sector as government and industry leaders came together for the UK Life Science Council meeting in No 10 Downing Street. It’s the pinnacle of the partnership working – forged and deepened through our joint work in the pandemic – and the BIA was at the heart of the action-progressing key agendas on behalf of members.

Member spotlight: supercharging drug discovery with Carterra

In our latest member spotlight blog, Josh Eckman, Founder and CEO of Carterra, details the Carterra's journey, from disrupting an already established industry as a start-up, to assisting in the development of the first Covid19 therapeutic antibody.

In2scienceUK, promoting diversity and inclusion within STEM

In2scienceUK is a charity that empowers young people from low-income backgrounds to reach their potential and progress to careers in Science, Technology, Engineering and Mathematics (STEM)

 

Latest resources

Here's a selection of featured BIA resources. Explore our Resources Hub  

Flexible Apprenticeships in the Life Sciences sector - Manual

The government's flexible apprenticeships manual which outlines how to effectively implement the flexi job model.

Guide to the Government for BIA members - May 2023

BIA member's guide to the government: This document provides an extensive guide to the Government for BIA Members, with focus on recent government changes and newly created Department for Science, Innovation and Technology

Influencing and shaping our sector | BIA update: January - April 2023

Advocating for the life science and biotech sector: report on how BIA is influencing change with government stakeholders.

USIT Guide

 

Join us at the next BIA event!

WiB West London card.jpg 1

Women in Biotech - West London

Scale Space, London
LSLS 2023 Website event listing banner.png

Life Science Leadership Summit 2023

Fanhams Hall
BIA Summer party - Website event listing banner.png

BIA Summer Party 2023

The Langham Hotel, London, London